PTH inactivates the AKT survival pathway in the colonic cell line Caco-2

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1803, Issue 3, 2010, Pages 343-351

  Calvo, Natalia ^a   de Boland, Ana Russo ^a   Gentili, Claudia ^a  

^a UNIVERSIDAD NACIONAL DEL SUR   (Argentina)

Author keywords

AKT; Apoptosis; Caco 2 cell; PP2A; PTH

Indexed keywords

CASPASE 3; CYCLIC AMP; MITOGEN ACTIVATED PROTEIN KINASE P38; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PARATHYROID HORMONE; PHOSPHOPROTEIN PHOSPHATASE 2; PROTEIN 14 3 3; PROTEIN BAD; PROTEIN KINASE B; PROTEIN KINASE C;

APOPTOSIS; ARTICLE; CELL FRACTIONATION; CELL PROLIFERATION; CELL STRAIN CACO 2; CELL VIABILITY; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOCYTOCHEMISTRY; IMMUNOPRECIPITATION; INTESTINE CELL; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; WESTERN BLOTTING;

14-3-3 PROTEINS; APOPTOSIS; BCL-ASSOCIATED DEATH PROTEIN; CACO-2 CELLS; CELL SURVIVAL; CYCLIC AMP; HUMANS; MITOCHONDRIA; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PARATHYROID HORMONE; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN PHOSPHATASE 2; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 77249101227     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2009.11.011     Document Type: Article

References (83)

1. Kerr J.F., Wyllie A.H., and Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26 4 (1972) 239-257
2. Nagata S. Apoptosis by death factor. Cell 88 3 (1997) 355-365
3. Gross A., McDonnell J.M., and Korsmeyer S.J. BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 13 15 (1999) 1899-1911
4. Strasser A., O'Connor L., and Dixit V.M. Apoptosis signaling. Annu. Rev. Biochem. 69 (2000) 217-245
5. Tsujimoto Y., and Shimizu S. Bcl-2 family: life-or-death switch. FEBS Lett. 466 (2000) 6-10
6. Franke T.F., Hornik C.P., Segev L., Shostak G.A., and Sugimoto C. PI3K/AKT and apoptosis: size matters. Oncogene 22 (2003) 8983-8998
7. Manning B.D., and Cantley L.C. AKT/PKB signaling: navigating downstream. Cell 129 (2007) 1261-1274
8. Yamada K.M., Araki M., and Tumor suppressor P. Modulator of cell signalling, growth, migration, and apoptosis. J. Cell. Sci. 114 (2001) 2375-2382
9. Chen C.S., Weng S.C., Tseng P.H., Lin H.P., and Chen C.S. Histone acetylation-independent effect of histone deacetylase inhibitors on AKT through the reshuffling of protein phosphatase 1 complexes. J. Biol. Chem. 280 (2005) 38879-38887
10. Xu W., Yuan X., Jung Y.J., Yang Y., Basso A., Rosen N., Chung E.J., Trepel J., and Neckers L. The heat shock protein 90 inhibitor geldanamycin and the ErbB inhibitor ZD1839 promote rapid PP1 phosphatase-dependent inactivation of AKT in ErbB2 overexpressing breast cancer cells. Cancer Res. 63 (2003) 7777-7784
11. Beaulieu J.M., Sotnikova T.D., Marion S., Lefkowitz R.J., Gainetdinov R.R., and Caron M.G. An AKT/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 122 (2005) 261-273
12. Van Kanegan M.J., Adams D.G., Wadzinski B.E., and Strack S. Distinct protein phosphatase 2A heterotrimers modulate growth factor signaling to extracellular signal-regulated kinases and AKT. J. Biol. Chem. 280 (2005) 36029-36036
13. Rocher G., Letourneux C., Lenormand P., and Porteu F. Inhibition of B56-containing protein phosphatase 2As by the early response gene IEX-1 leads to control of AKT activity. J. Biol. Chem. 282 (2007) 5468-5477
14. Gao T., Furnari F., and Newton A.C. PHLPP: a phosphatase that directly dephosphorylates AKT, promotes apoptosis, and suppresses tumor growth. Mol. Cell 18 (2005) 13-24
15. Brognard J., Sierecki E., Gao T., and Newton A.C. PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of AKT signaling by regulating distinct AKT isoforms. Mol. Cell 25 (2007) 917-931
16. Gensure R.C., Gardella T.J., and Juppner H. Parathyroid hormone and parathyroid hormone-related peptide, and their receptors. Biochem. Biophys. Res. Commun. 328 (2005) 666-678
17. Murray T.M., Rao L.G., Divieti P., and Bringhurst F.R. Parathyroid hormone secretion and action: evidence for discrete receptors for the carboxyl-terminal region and related biological actions of carboxyl-terminal ligands. Endocrinology 26 (2005) 78-113
18. Gentili C., Morelli S., and Russo de Boland A. Characterization of PTH/PTHrP receptor in rat duodenum: effects of ageing. J. Cell. Biochem. 88 (2003) 1157-1167
19. Urena P., Kong X.F., Abou-Samra A.B., Juppner H., Kronenberg H.M., Potts Jr. J.T., and Segre G.V. Parathyroid hormone (PTH)/PTH-related peptide receptor messenger ribonucleic acids are widely distributed in rat tissues. Endocrinology 133 (1993) 617-623
20. Massheimer V., Picotto G., Boland R., and Russo de Boland A. Effect of aging on the mechanisms of PTH-induced calcium influx in rat intestinal cells. J. Cell. Physiol. 182 (2000) 429-437
21. Gentili C., Boland R., and Russo de Boland A. PTH stimulates PLCbeta and PLCgamma isoenzymes in rat enterocytes: influence of ageing. Cell. Signal. 13 (2001) 131-138
22. Picotto G., Massheimer V., and Boland R. Parathyroid hormone stimulates calcium influx and the cAMP messenger system in isolated rat duodenal cells. Am J Physiol 273 (1997) C1349-C1353
23. Gentili C., and Russo de Boland A. Age-related decline in mitogen-activated protein kinase phosphorylation in PTH-stimulated rat enterocytes. Exp. Gerontology. 35 (2000) 1003-1015
24. Buzzi N., Boland R., and Russo de Boland A. PTH regulation of c-JUN terminal kinase and p38 MAPK cascades in intestinal cells from young and aged rats. Biogerontology 8 (2007) 189-199
25. Ramachandran A., Madesh M., and Balasubramanian K.A. Apoptosis in the intestinal epithelium: its relevance in normal and pathophysiological conditions. J. Gastroenterol. Hepatol. 15 (2000) 109-120
26. Butler L.M., Hewett P.J., Fitridge R.A., and Cowled P.A. Deregulation of apoptosis in colorectal carcinoma: theoretical and therapeutics implications. Aust. NZ. J. Surg. 69 (1999) 88-94
27. Zerega B., Cermelli S., Bianco P., Cancedda R., and Cancedda F.D. Parathyroid hormone [PTH(1-34)] and parathyroid hormone related protein [PTHrP(1-34)] promote reversion of hypertrophic chondrocytes to a prehypertrophic proliferating phenotype and prevent terminal differentiation of osteoblast-like cells. J. Miner. Res. 14 (1999) 1281-1289
28. Turner P.R., Mefford S., Christakos S., and Nissenson R.A. Apoptosis mediated by activation of the G protein-coupled receptor for parathyroid hormone (PTH)/PTH-related protein (PTHrP). Mol. Endocrinol 14 (2000) 241-254
29. Chen H., Demiralp B., Schneider A., Koh A., Silve C., Wang C., and McCauley L.K. Parathyroid hormone and parathyroid hormone-related protein exert both pro- and anti-apoptotic effects in mesenchymal cells. J. Biol. Chem. 277 (2002) 19374-19381
30. Calvo N., German O.L., Russo de Boland A., and Gentili C. Pro-apoptotic effects of PTH in intestinal cells. Biochem. Cell. Biol. 87 (2009) 389-400
31. Calvo N., Gentili C., and Russo de Boland A. The early phase of programmed cell death in caco-2 intestinal cells exposed to PTH. J. Cell. Biochem. 105 (2008) 989-997
32. Bradford M. A rapid and sensitive method for quantification of microgram quantities of proteins utilizing the principle of protein binding. Anal. Biochem. 72 (1976) 248-254
33. Minamikawa T., Sriratana A., Williams D.A., Bowser D.N., Hill J.S., and Nagley P.J. Chloromethyl-X-rosamine (MitoTracker Red) photosensitises mitochondria and induces apoptosis in intact human cells. Cell Sci. 112 (1999) 2419-2430
34. Ishihara H., Martin B.L., Brautigan D.L., Karaki H., Ozaki H., Kato Y., Fusetani N., Watabe S., Hashimoto K., Uemura D., and Hartshorne D.J. Calyculin A and okadaic acid: inhibitors of protein phosphatase activity. Biochem. Biophys. Res. Commun. 159 (1989) 871-877
35. Cohen P., Holmes C.F.B., and Tsukitani Y. Okadaic acid: a new probe for the study of cellular regulation. Trends Biochem. Sci. 15 (1990) 98-102
36. Guan L., Song K., Pysz M.A., Curry K.J., Hizli A.A., Danielpour D., Black A.R., and Black J.D. Protein kinase C-mediated down-regulation of cyclin D1 involves activation of the translational repressor 4E-BP1 via a phosphoinositide 3-kinase/AKT-independent, protein phosphatase 2A-dependent mechanism in intestinal epithelial cells. J. Biol. Chem. 282 (2007) 14213-14225
37. Rane M.J., Coxon P.Y., Powell D.W., Webster R., Klein J.B., Pierce W., Ping P., and McLeish K. p38 Kinase-dependent MAPKAPK-2 activation functions as 3-phosphoinositide-dependent kinase-2 for AKT in human neutrophils. J. Biol. Chem. 276 (2001) 3517-3523
38. Taniyama Y., Ushio-Fukai M., Hitomi H., Rocic P., Kingsley M.J., Pfahnl C., Weber D.S., Alexander R.W., and Griendling K.K. Role of p38 MAPK and MAPKAPK-2 in angiotensin II-induced AKT activation in vascular smooth muscle cells. Am. J. Physiol. Cell Physiol. 287 (2004) C494-C499
39. Bommakanti R.K., Vinayak S., and Simonds W.F. Dual regulation of AKT/protein kinase B by heterotrimeric G protein subunits. J. Biol. Chem. 275 (2000) 38870-38876
40. Filippa N., Sable C.L., Filloux C., Hemmings B., and Van Obberghen E. Mechanism of protein kinase B activation by cyclic AMP-dependent protein kinase. Mol. Cell. Biol. 19 (1999) 4989-5000
41. Fujita H., Ogino T., Kobuchi H., Fujiwara T., Yano H., Akiyama J., Utsumi K., and Sasaki J. Cell-permeable cAMP analog suppresses 6-hydroxydopamine-induced apoptosis in PC12 cells through the activation of the AKT pathway. Brain Res. 1113 (2006) 10-23
42. Brennesvik E.O., Ktori C., Ruzzin J., Jebens E., Shepherd P.R., and Jensen J. Adrenaline potentiates insulin-stimulated PKB activation via cAMP and Epac: implications for cross talk between insulin and adrenaline. Cell. Signal. 17 (2005) 1551-1559
43. Lou L., Urbani J., Ribeiro-Neto F., and Altschuler D.L. cAMP inhibition of AKT is mediated by activated and phosphorylated Rap1b. J. Biol. Chem. 277 (2002) 32799-32806
44. Poser S., Impey S., Xia Z., and Storm D.R. Brain-derived neurotrophic factor protection of cortical neurons from serum withdrawal-induced apoptosis is inhibited by cAMP. J. Neurosci. 23 (2003) 4420-4427
45. Feschenko M.S., Stevenson E., Nairn A.C., and Sweadner K.J. A novel cAMP-stimulated pathway in protein phosphatase 2A activation. J. Pharmacol. Exp. Ther. 302 (2002) 111-118
46. Moon E.Y., and Lerner A. PDE4 inhibitors activate a mitochondrial apoptotic pathway in chronic lymphocytic leukemia cells that is regulated by protein phosphatase 2A. Blood 101 (2003) 4122-4130
47. Fu H., Subramanian R.R., and Masters S.C. 14-3-3 proteins: structure, function, and regulation. Ann. Rev. Pharmacol. Toxicol. 40 (2000) 617-647
48. Yaffe M.B., Rittinger K., Volinia S., Caron P.R., Aitken A., Leffers H., Gamblin S.J., Smerdon S.J., and Cantley L.C. The structural basis for 14-3-3:phosphopeptide binding specificity. Cell 91 (1997) 961-971
49. Powell D.W., Rane M.J., Chen Q., Singh S., and McLeish K.R. Identification of 14-3-3 Zeta as a protein kinase B/AKT substrate. J. Biol. Chem. 277 (2002) 21639-21642
50. Zha J., Harada H., Yang E., Jockel J., and Korsmeyer S.J. Serine phosphorylation of death agonist Bad in response to survival factor results in binding to 14-3-3 not BCL-XL. Cell 87 (1996) 619-628
51. Gentili C., Morelli S., and Russo de Boland A. Involvement of PI3-kinase and its association with c-Src in PTH-stimulated rat enterocytes. J. Cell. Biochem. 86 (2002) 773-783
52. Gentili C., Boland R., and Russo de Boland A. Implication of G βγ proteins and c-Src tyrosine kinase in PTH-induced signal transduction in rat enterocytes. J. Endocrinol. 188 (2006) 69-78
53. Strack S., Cribbs J.T., and Gomez L. Critical role for protein phosphatase 2A heterotrimers in mammalian cell survival. J. Biol. Chem. 279 (2004) 47732-47739
54. Janssens V., and Goris J. Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signaling. Biochem. J. 353 (2001) 417-439
55. Virshup D.M. Protein phosphatase 2A: a panoply of enzymes. Curr. Opin. Cell Biol. 12 (2000) 180-185
56. Hubbard M.J., and Cohen P. On target with a new mechanism for the regulation of protein phosphorylation. Trends Biochem. Sci. 18 (1993) 172-177
57. Lee T.H., Solomon M.J., Mumby M.C., and Kirschner M.W. INH, a negative regulator of MPF, is a form of protein phosphatase 2A. Cell 64 (1991) 415-423
58. Deng X., Ito T., Carr B., Mumby M., and May Jr. W.S. Reversible phosphorylation of Bcl2 following interleukin 3 or bryostatin 1 is mediated by direct interaction with protein phosphatase 2A. J. Biol. Chem. 273 (1998) 34157-34163
59. Song Q., and Lavin M.F. Calyculin A, a potent inhibitor of phosphatases-1 and -2A, prevents apoptosis. Biochem. Biophys. Res. Commun. 190 (1993) 47-55
60. Scheidtmann K.H., Mumby M.C., Rundell K., and Walter G. Dephosphorylation of simian virus 40 large-T antigen and p53 protein by protein phosphatase 2A: inhibition by small t antigen. Mol. Cell. Biol. 11 (1991) 1996-2003
61. Dagda R.K., Barwacz C.A., Cribbs J.T., and Strack S.J. Unfolding-resistant translocase targeting: a novel mechanism for outer mitochondrial membrane localization exemplified by the Bbeta2 regulatory subunit of protein phosphatase 2A. Biol. Chem. 280 (2005) 27375-27382
62. Dagda R.K., Merrill R.A., Cribbs J.T., Chen Y., Hell J.W., Usachev Y.M., and Strack S. The spinocerebellar ataxia 12 gene product and protein phosphatase 2A regulatory subunit Bbeta2 antagonizes neuronal survival by promoting mitochondrial fission. J. Biol. Chem. 283 (2008) 36241-36248
63. Ruvolo P.P., Deng X., Ito T., Carr B.K., and May W.S. Ceramide induces Bcl2 dephosphorylation via a mechanism involving mitochondrial PP2A. J. Biol. Chem. 274 (1999) 20296-20300
64. Ruvolo P.P., Clark W., Mumby M., Gao F., and May W.S. A functional role for the B56 alpha-subunit of protein phosphatase 2A in ceramide-mediated regulation of Bcl2 phosphorylation status and function. J. Biol. Chem. 277 (2002) 22847-22852
65. Grethe S., and Pörn-Ares I.M. p38 MAPK regulates phosphorylation of Bad via PP2A-dependent suppression of the MEK1/2-ERK1/2 survival pathway in TNF-alpha induced endothelial apoptosis. Cell. Signal 18 (2006) 531-540
66. Liu Q., and Hofmann P.A. Protein phosphatase 2A-mediated cross-talk between p38 MAPK and ERK in apoptosis of cardiac myocytes. Am. J. Physiol, Heart Circ. Physiol. 286 (2004) 2204-2212
67. Avdi N.J., Malcolm K.C., Nick J.A., and Worthen G.S. A role for protein phosphatase-2A in p38 mitogen-activated protein kinase-mediated regulation of the c-Jun NH(2)-terminal kinase pathway in human neutrophils. J. Biol. Chem. 277 (2002) 40687-40696
68. Keyse S.M. Protein phosphatases and the regulation of mitogen-activated protein kinase signaling. Curr. Opin. Cell Biol. 12 (2000) 186-192
69. Hsiung S.C., Tin A., Tamir H., Franke T.F., and Liu K.P. Inhibition of 5-HT1A receptor-dependent cell survival by cAMP/protein kinase A: role of protein phosphatase 2A and Bax. J. Neurosci. Res 86 (2008) 2326-2338
70. Hong K., Lou L., Gupta S., Ribeiro-Neto F., and Altschuler D.L. A novel Epac-Rap-PP2A signaling module controls cAMP-dependent AKT regulation. J. Biol. Chem. 283 (2008) 23129-23138
71. Ahn J.H., McAvoy T., Rakhilin S.V., Nishi A., Greengard P., and Nairn A.C. Protein kinase A activates protein phosphatase 2A by phosphorylation of the B56delta subunit. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 2979-2984
72. Usui H., Inoue R., Tanabe O., Nishito Y., Shimizu M., Hayashi H., Kagamiyama H., and Takeda M. Activation of protein phosphatase 2A by cAMP-dependent protein kinase-catalyzed phosphorylation of the 74-kDa B″ (delta) regulatory subunit in vitro and identification of the phosphorylation sites. FEBS Lett. 430 (1998) 312-316
73. McEwan D.G., Brunton V.G., Baillie G.S., Leslie N.R., Houslay M.D., and Frame M.C. Chemoresistant KM12C colon cancer cells are addicted to low cyclic AMP levels in a phosphodiesterase 4-regulated compartment via effects on phosphoinositide 3-kinase. Cancer Res. 67 (2007) 5248-5257
74. Murata K., Sudo T., Kameyama M., Fukuoka H., Mukai M., Doki Y., Sasaki Y., Ishikawa O., Kimura Y., and Imaoka S. Cyclic AMP specific phosphodiesterase activity and colon cancer cell motility. Clin. Exp. Metastasis 18 (2001) 599-604
75. Macchia V., Gargiulo M., Terracciano D., Di Carlo A., and Mariano A. Cyclic AMP-dependent secretion of Ca 19-9 by LS174T human colon carcinoma cells. Oncol. Rep. 9 (2002) 387-391
76. Cardone M.H., Roy N., Stennicke H.R., Salvesen G.S., Franke T.F., Stanbridge E., Frisch S., and Reed J.C. Regulation of cell death protease caspase-9 by phosphorylation. Science 282 (1998) 1318-1321
77. Liu W., Akhand A.A., Takeda K., Kawamoto Y., Itoigawa M., Kato M., Suzuki H., Ishikawa N., and Nakashima I. Protein phosphatase 2A-linked and -unlinked-dependent pathways for downregulation of AKT kinase triggered by 4-hydroxynonenal. Cell Death Differ. 10 (2003) 772-781
78. Acs P., Szallasi Z., Kazanietz M.G., and Blumberg P.M. Differential activation of PKC isozymes by 14-3-3 zeta protein. Biochem. Biophys. Res. Commun. 216 (1995) 103-109
79. Hausser A., Storz P., Link G., Stoll H., Liu Y., Altman A., Pfizenmair K., and Johannes F. Protein kinase C mu is negatively regulated by 14-3-3 signal transduction proteins. J. Biol. Chem. 274 (1999) 9258-9264
80. Meller N., Liu Y.C., Collins T.L., Bonnefoy-Berard N., Baier G., Isakov N., and Altman A. Direct interaction between protein kinase C theta (PKC theta) and 14-3-3 tau in T cells: 14-3-3 overexpression results in inhibition of PKC theta translocation and function. Mol. Cell. Biol. 16 (1996) 5782-5791
81. Megidish T., Cooper J., Zhang L., Fu H., Hakomori S., and novel sphingosine-dependent protein kinase A. (SDK1) specifically phosphorylates certain isoforms of 14-3-3 protein. J. Biol. Chem. 273 (1998) 21834-21845
82. Dubois T., Rommel C., Howell S., Steinhussen U., Soneji Y., Morrice N., Moelling K., and Aitken A. 14-3-3 Is phosphorylated by casein kinase I on residue 233. Phosphorylation at this site in vivo regulates Raf/14-3-3 interaction. J. Biol. Chem. 272 (1997) 28882-28888
83. Yaffe M.B., Leparc G.G., Lai J., Obata T., Volinia S., and Cantley L.C. A motif-based profile scanning approach for genome-wide prediction of signaling pathways. Nat. Biotechnol. 4 (2001) 348-353